Digital Agenda for Europe
A Europe 2020 Initiative

Benefiting from personalised care

Article
Main image: 
Keyboard_Medical
More effective care starts with a more precise diagnosis, based on the patient’s health history and current situation. ICT helps health professionals improve diagnosis and adapt treatments to the patient’s specific needs and profile.
Share this

The euHeart project builds computer models of the diseased heart to personalise and optimise the selection of the most appropriate treatment in several cardiovascular diseases such as heart failure and heart rhythm disorders, and also coronary artery, valvular and aortic diseases. The simulation tools can be used by doctors to predict the outcome of different types of therapy. The result is not only beneficial to patients, who get personalised and safe care, but also to society, thanks to lower medical costs.

Epilepsy is the most common brain disorder, affecting 1-2% of the population, especially children and adolescents. The ARMOR project will use modern monitoring and communication technologies to provide healthcare specialists with a framework for the monitoring and analysis of epilepsy-relevant multi-parametric data. The specificity of each patient and the need for constant adjustment of the treatments will be addressed through a Personal Health System (PHS) to achieve flexible monitoring and efficient diagnosis management.

Assessing how degenerative disorders affect individuals leads to more accurate management of each case but also to progress on future treatments for currently incurable diseases. According to a multi-perspective approach, the SENSE-PARK project addresses Parkinson's disease by combining technological expertise from technology with the experiences of patients and the scientific know-how of health professionals. It will develop a novel sensor information and data capture system to provide patients with daily valuable information on their health status and help doctors and researchers progress in diagnoses, treatments and therapeutic trials.